Uwe Platzbecker, MD, is the Director of the Clinic and Polyclinic for Hematology, Cell Therapy and Hemostaseology at the Leipzig University Hospital, Leipzig, Germany
Prof. Platzbecker completed his medical studies at the Technical University of Dresden, Dresden, Germany, qualifying in 1996. He then obtained his doctorate in medicine in 1997. Prof. Platzbecker moved to Seattle to complete his post doctorate degree in 2001 at the Fred Hutchinson Cancer Research Center, Seattle, WA, and then received his professorship for translational hematology at the Technical University of Dresden in 2012.
Speaking on myelodysplastic syndromes and myeloid leukemia
Prof. Platzbecker’s research interests are primarily focused on myelodysplastic syndromes (MDS) and its treatment. Specifically, Prof. Platzbecker’s team has worked on trials assessing luspatercept and imetelstat in patients with lower-risk MDS, and most recently on a Phase I trial of a novel oral IRAK4 inhibitor for relapsed/refractory high-risk MDS or acute myeloid leukemia.